vs
Side-by-side financial comparison of Axil Brands, Inc. (AXIL) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.
Axil Brands, Inc. is the larger business by last-quarter revenue ($8.1M vs $7.0M, roughly 1.2× Relay Therapeutics, Inc.). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $-235.9M).
Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
AXIL vs RLAY — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $7.0M |
| Net Profit | $704.9K | — |
| Gross Margin | 68.1% | — |
| Operating Margin | 11.1% | — |
| Net Margin | 8.7% | — |
| Revenue YoY | 5.2% | — |
| Net Profit YoY | 11.2% | — |
| EPS (diluted) | $0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.1M | $7.0M | ||
| Q3 25 | $6.9M | $0 | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | $6.9M | $7.7M | ||
| Q4 24 | $7.7M | $0 | ||
| Q3 24 | $5.9M | $0 | ||
| Q2 24 | $6.5M | $0 | ||
| Q1 24 | $6.5M | $10.0M |
| Q4 25 | $704.9K | — | ||
| Q3 25 | $334.3K | $-74.1M | ||
| Q2 25 | $-245.6K | — | ||
| Q1 25 | $576.7K | $-77.1M | ||
| Q4 24 | $633.7K | — | ||
| Q3 24 | $-109.8K | $-88.1M | ||
| Q2 24 | $49.5K | $-92.2M | ||
| Q1 24 | $781.1K | $-81.4M |
| Q4 25 | 68.1% | — | ||
| Q3 25 | 67.6% | — | ||
| Q2 25 | 70.0% | — | ||
| Q1 25 | 71.7% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 71.0% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 71.5% | — |
| Q4 25 | 11.1% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 8.4% | -1105.2% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | -2.4% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | -1.6% | -903.0% |
| Q4 25 | 8.7% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | -4.3% | — | ||
| Q1 25 | 8.3% | -1003.6% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | -1.9% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 12.1% | -813.3% |
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.04 | $-0.43 | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $0.07 | $-0.46 | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $-0.02 | $-0.63 | ||
| Q2 24 | $0.11 | $-0.69 | ||
| Q1 24 | $0.04 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $84.0M |
| Total DebtLower is stronger | $138.3K | — |
| Stockholders' EquityBook value | $11.1M | $567.1M |
| Total Assets | $16.2M | $621.3M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | $84.0M | ||
| Q3 25 | $4.1M | $91.6M | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $4.7M | $93.5M | ||
| Q4 24 | $5.2M | $124.3M | ||
| Q3 24 | $4.1M | $152.4M | ||
| Q2 24 | $3.3M | $134.1M | ||
| Q1 24 | $4.9M | $152.9M |
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | — | ||
| Q2 24 | $146.6K | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.1M | $567.1M | ||
| Q3 25 | $10.2M | $607.7M | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $9.7M | $721.1M | ||
| Q4 24 | $8.8M | $777.8M | ||
| Q3 24 | $7.9M | $838.9M | ||
| Q2 24 | $7.7M | $681.7M | ||
| Q1 24 | $8.8M | $745.8M |
| Q4 25 | $16.2M | $621.3M | ||
| Q3 25 | $15.4M | $670.0M | ||
| Q2 25 | $12.9M | — | ||
| Q1 25 | $13.0M | $799.4M | ||
| Q4 24 | $13.7M | $871.3M | ||
| Q3 24 | $11.4M | $930.1M | ||
| Q2 24 | $11.0M | $772.5M | ||
| Q1 24 | $12.7M | $841.4M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $934.8K | $-235.5M |
| Free Cash FlowOCF − Capex | $906.4K | $-235.9M |
| FCF MarginFCF / Revenue | 11.1% | -3370.0% |
| Capex IntensityCapex / Revenue | 0.3% | 5.9% |
| Cash ConversionOCF / Net Profit | 1.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-622.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $934.8K | $-235.5M | ||
| Q3 25 | $-739.2K | $-62.1M | ||
| Q2 25 | $194.4K | — | ||
| Q1 25 | $-169.9K | $-73.2M | ||
| Q4 24 | $1.0M | $-249.1M | ||
| Q3 24 | $897.3K | $-75.1M | ||
| Q2 24 | $-336.6K | $-65.8M | ||
| Q1 24 | $-912.8K | $-50.3M |
| Q4 25 | $906.4K | $-235.9M | ||
| Q3 25 | $-747.6K | $-62.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-258.2K | $-73.6M | ||
| Q4 24 | $941.1K | $-251.1M | ||
| Q3 24 | — | $-75.3M | ||
| Q2 24 | $-394.9K | $-65.8M | ||
| Q1 24 | $-922.1K | $-52.1M |
| Q4 25 | 11.1% | -3370.0% | ||
| Q3 25 | -10.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -3.7% | -958.4% | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | -14.3% | -520.7% |
| Q4 25 | 0.3% | 5.9% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.3% | 5.0% | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.1% | 17.8% |
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
RLAY
Segment breakdown not available.
